Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201111095 Principal Investigator: Ghobadi, Armin
Title: An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE antibody blinatumomab in Adult Patients with Relapsed/Refractory B-precursor acute lymphoblastic leukemia (ALL)
Phase: II Disease Site: Lymphoid Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out how safe a continuous infusion of blinatumomab is and how well it works in patients with B-precursor ALL who have not responded to previous therapy or have suffered a relapse.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)